Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
UBE2V1 pseudogene 7 (UBE2V1P7) is a non-protein-coding pseudogene. While the related UBE2V1 gene encodes a variant E2 ubiquitin-conjugating enzyme involved in cell cycle regulation, DNA repair, and signaling, UBE2V1P7 itself has no demonstrated protein product, functional role, or disease association. It should not be considered a therapeutic target or receptor. The designation "pseudogene" indicates it represents a non-functional copy or fragment related to the functional UBE2V1 gene[5]. UBE2V1P7 is explicitly labeled as a pseudogene in genetic databases and does not encode an active protein product nor act as a known molecular target[5]. All functional information—including enzymatic activity, involvement in cell cycle, signaling, DNA repair—applies to the *functional* UBE2V1 gene, **not** to UBE2V1P7[1][3][4]. No biological function, drug interactions, or disease associations are reported or expected for UBE2V1P7[5]. There is no evidence it serves as a biomarker or presents safety concerns in therapeutic contexts.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ubiquitin conjugating enzyme E2 V1 pseudogene 7 (UBE2V1P7).